MARKET

CATX

CATX

Perspective Therapeutics Inc
AMEX
0.2500
-0.0038
-1.50%
Pre Market: 0.2596 +0.0096 +3.84% 08:02 11/30 EST
OPEN
0.2575
PREV CLOSE
0.2538
HIGH
0.2602
LOW
0.2500
VOLUME
2
TURNOVER
0
52 WEEK HIGH
0.7298
52 WEEK LOW
0.2050
MARKET CAP
70.14M
P/E (TTM)
-3.7936
1D
5D
1M
3M
1Y
5Y
Perspective Therapeutics Inc: Current report
Press release · 1d ago
Perspective Therapeutics Announces First Ever Human SPECT Imaging Of Pb-212 With VMT-α-NET By Clinical Collaborators In Germany
Imaging was conducted as part of a clinical study at technical university of dresden in germany image was selected as "image of the month" in the european journal of nuclear medicine and molecular imaging, november 2023. Perspective therapeutics published first human spect images utilizing the alpha-emitting isotope of 212pb.
Benzinga · 2d ago
Weekly Report: what happened at CATX last week (1120-1124)?
Weekly Report · 3d ago
Weekly Report: what happened at CATX last week (1113-1117)?
Weekly Report · 11/20 09:44
Perspective Therapeutics files for $200M mixed shelf
Perspective therapeutics files for $200m mixed shelf offering to raise up to $200 million. The company filed a prospectus related to a mixed-shelf offering on nov. 17. Perspective therapeutic is a biopharmaceutical company with a focus on rare diseases.
Seeking Alpha · 11/17 22:30
Perspective Therapeutics Inc: Current report
Press release · 11/17 22:10
Oppenheimer Sticks to Their Buy Rating for Perspective Therapeutics (CATX)
TipRanks · 11/16 12:56
JonesTrading Initiates Coverage On Perspective Therapeutics with Buy Rating, Announces Price Target of $1.4
Benzinga · 11/15 10:30
More
About CATX
Perspective Therapeutics, Inc. is a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents. The Company is focused on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies, so its targeted medical doses are delivered directly to the tumor site. The Company’s core product is its Cesium-131 sealed source brachytherapy seed. These seeds can be inserted individually or in combination into various locations in the body. The Company also sells seeds in strands to keep them from individually moving. The Company’s segments are Brachytherapy and Drug Operations. Brachytherapy includes sales and manufacturing of Cesium-131 brachytherapy seeds, including research and development of new applications for the seeds. Drug Operations includes research and development and clinical operations related to the use of Lead-203 and Lead-212 as a diagnostic and a therapeutic drug.

Webull offers Perspective Therapeutics Inc stock information, including AMEX: CATX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CATX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CATX stock methods without spending real money on the virtual paper trading platform.